Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial

Antolín Novoa, Silvia
Thumbnail
Statistics
Statistics
Identifiers
Identifiers
URI: http://hdl.handle.net/20.500.11940/7625
PMID: 21717449
ISSN: 0008-543X
Full record
Services
Services
RISMendeleyLinksolver
Date issued
2012
Journal title
CANCER
Type of content
Artigo